https://www.selleckchem.com/pr....oducts/ccg-203971.ht
20; 95% CI, 0.09-0.46). A propensity score-weighting analysis demonstrated similar findings (adjusted OR, 0.18; 95% CI, 0.10-0.3. Subgroup analysis showed a significant survival benefit among those who were severely (adjusted OR, 0.07; 95% CI, 0.02-0.23) and critically ill (adjusted OR, 0.32; 95% CI, 0.15-0.65), as well as among the elderly patients' age 65, IL-6 10 times upper limit level, and D-dimer 5 times upper limit level. Among hospitalized COVID-19 patients, LMWH use was associated with lower all-cause in-hos
Like
Comment
Share
